Table 4.
Gender Differences in the Prevalence, Demographic and Clinical Features of LH in DM Patients (Mixed Juvenile and Adult DM)
| Author (Year) | Male | Female | All | P-value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | LH Prevalence (%) | Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | LH Prevalence (%) | Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | Overall | LH Prevalence (%) | ||
| Yan et al (2021)30 | 57(55.34%) | 25(64.10%) | 69.51% | 46(44.66%) | 14(35.90%) | 76.67% | 103(72.54%) | 39(27.46%) | 142 | 72.54% | 0.3454 |
| Barola et al (2018)31 | 139(60.17%) | 65(46.10%) | 68.14% | 92(39.83%) | 76(53.90%) | 54.76% | 231(62.10%) | 141(37.90%) | 372 | 62.10% | 0.0081 |
| Gupta et al (2018)32 | 50(51.55%) | 25(59.52%) | 66.67% | 47(48.45%) | 17(40.48%) | 73.44% | 97(69.78%) | 42(30.22%) | 139 | 69.78% | 0.3862 |
| Blanco et al (2013)9 | 142(52.21%) | 79(52.32%) | 64.25% | 130(47.79%) | 72(47.68%) | 64.36% | 277(64.42%) | 153(35.58%) | 430 | 64.42% | 0.9824 |
| Vardar et al (2007)34 | 35(33.65%) | 33(32.67%) | 51.47% | 69(66.35%) | 68(67.33%) | 50.36% | 104(48.37%) | 111(51.63%) | 215 | 48.37% | >0.9999 |
| Total | 423(52.42%) | 227(47.89%) | 65.08% | 384(47.58%) | 247(52.11%) | 60.86% | 812(62.56%) | 486(37.44%) | 1298 | 62.56% | 0.1187 |